Status:
WITHDRAWN
Prophylactic Analgesia for Bladder Botox Injections
Lead Sponsor:
Montefiore Medical Center
Conditions:
Urinary Incontinence
Urinary Incontinence, Urge
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to learn more about using phenazopyridine (Pyridium) for pain control during bladder onabotulinumtoxinA ("botox") injections for surgical management of overactive bl...
Detailed Description
Urinary incontinence poses personal and emotional hardships to the patients who experience it. Urge urinary incontinence (UUI) is often a result of overactive bladder (OAB) and may exist in combinatio...
Eligibility Criteria
Inclusion
- Women
- 18 years or older
- Planning to undergo surgical management of idiopathic overactive bladder with intradetrusor onabotulinumtoxinA injection at Montefiore Medical Center Female Pelvic Medicine Reconstructive Surgery Department
- Provided informed consent
Exclusion
- Currently pregnant
- Current Urinary Tract Infection (UTI)
- Neurogenic bladder diagnosis
- Received pelvic radiotherapy
- Severe cognitive impairment
- Non-English or non-Spanish speaking.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06514430
Start Date
July 1 2025
End Date
February 1 2026
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center Female Pelvic Medicine Reconstructive Surgery Department
The Bronx, New York, United States, 10467